| Issue Date | Title | Author(s) |
| 2017 | Influencing Selectivity to Cancer Cells with Mixed Nanoparticles Prepared from Albumin-Polymer Conjugates and Block Copolymers | Jiang, YY; Wong, S; Chen, F; Chang, T; Lu, HX; Stenzel, MH |
| 2016-05-24 | Engineering a 3D microfluidic culture platform for tumor-treating field application. | Pavesi, A; Adriani, G; Tay, A; Warkiani, ME; Yeap, WH; Wong, SC; Kamm, RD |
| 2018-09-15 | Disruption of a 35 KB enhancer impairs CTCF binding and MLH1 expression in colorectal cells | Liu, Q; Thoms, JAI; Nunez, AC; Huang, Y; Knezevic, K; Packham, D; Poulos, RC; Williams, R; Beck, D; Hawkins, NJ; Ward, RL; Wong, JWH; Hesson, LB; Sloane, MA; Pimanda, JE |
| 2023 | A Microfluidic Approach for Enrichment and Single-Cell Characterization of Circulating Tumor Cells from Peripheral Blood. | Radfar, P; Ding, L; Es, HA; Warkiani, ME |
| 2023-03-28 | Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies. | Germon, ZP; Sillar, JR; Mannan, A; Duchatel, RJ; Staudt, D; Murray, HC; Findlay, IJ; Jackson, ER; McEwen, HP; Douglas, AM; McLachlan, T; Schjenken, JE; Skerrett-Byrne, DA; Huang, H; Melo-Braga, MN; Plank, MW; Alvaro, F; Chamberlain, J; De Iuliis, G; Aitken, RJ; Nixon, B; Wei, AH; Enjeti, AK; Huang, Y; Lock, RB; Larsen, MR; Lee, H; Vaghjiani, V; Cain, JE; de Bock, CE; Verrills, NM; Dun, MD |
| 2017-05-01 | Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma. | Zhang, W; Feng, Q; Wang, C; Zeng, X; Du, Y; Lin, L; Wu, J; Fu, L; Yang, K; Xu, X; Xu, H; Zhao, Y; Li, X; Schoenauer, UH; Stadlmayr, A; Saksena, NK; Tilg, H; Datz, C; Liu, X |
| 2023-04-01 | Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma. | Seneviratne, JA; Carter, DR; Mittra, R; Gifford, A; Kim, PY; Luo, J-S; Mayoh, C; Salib, A; Rahmanto, AS; Murray, J; Cheng, NC; Nagy, Z; Wang, Q; Kleynhans, A; Tan, O; Sutton, SK; Xue, C; Chung, SA; Zhang, Y; Sun, C; Zhang, L; Haber, M; Norris, MD; Fletcher, JI; Liu, T; Dilda, PJ; Hogg, PJ; Cheung, BB; Marshall, GM |
| 2023-07 | Pyrimido[1,2-a]benzimidazoles as inhibitors of oncoproteins ubiquitin specific protease 5 and MYCN in the childhood cancer neuroblastoma. | Gadde, S; Kleynhans, A; Holien, JK; Bhadbhade, M; Nguyen, PLD; Mittra, R; Yu, TT; Carter, DR; Parker, MW; Marshall, GM; Cheung, BB; Kumar, N |
| 2023-10-25 | Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Zhai, L; Balachandran, A; Larkin, R; Seneviratne, JA; Chung, SA; Lalwani, A; Tsubota, S; Beck, D; Kadomatsu, K; Beckers, A; Durink, K; De Preter, K; Speleman, F; Haber, M; Norris, MD; Swarbrick, A; Cheung, BB; Marshall, GM; Carter, DR |
